We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CON-TGO91-316 - Novartis Pharmaceuticals Australia Pty Ltd
Product names
- AUST R 160228 - RITALIN LA methylphenidate hydrochloride 10 mg modified release tablet
- AUST R 82957 - RITALIN LA methylphenidate hydrochloride 20 mg modified release tablet
- AUST R 82958 - RITALIN LA methylphenidate hydrochloride 30 mg modified release tablet
- AUST R 82959 - RITALIN LA methylphenidate hydrochloride 40 mg modified release tablet
- AUST R 236251 - RITALIN LA methylphenidate hydrochloride 60 mg modified release
- AUST R 11052 - RITALIN 10 methylphenidate hydrochloride 10 mg table blister pack
- AUST R 117306 - ARTIGE methylphenidate hydrochloride 10 mg tablet blister pack
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 30 April 2021.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines